Background
Previous evidence linking diabetes to Alzheimer’s disease (AD) neuropathology is mixed and scant data are available from low- and middle-income countries.
Objective
To investigate the association between diabetes and AD neuropathology in a large autopsy study of older Brazilian adults.
Methods
In this cross-sectional study, diabetes was defined by diagnosis during life or use of antidiabetic medication. A standardized neuropathological examination was performed using immunohistochemistry. The associations of diabetes with Consortium to Establish and Registry for Alzheimer Disease (CERAD) scores for neuritic plaques and Braak-Braak (BB) scores for neurofibrillary tangles were investigated using multivariable ordinal logistic regression. We investigated effect modification of education, race, and APOE on these associations.
Results
Among 1,037 subjects (mean age = 74.4 ± 11.5 y; mean education = 4.0 3.7 y; 48% male, 61% White), diabetes was present in 279 subjects. Diabetes was not associated with BB (OR = 1.12, 95%±CI = 0.81–1.54, p = 0.48) or with CERAD (OR = 0.97, 95% CI = 0.68–1.38, p = 0.86) scores on analyses adjusted for sociodemographic and clinical variables. We observed effect modification by the APOE allele ε4 on the association between diabetes mellitus and BB scores.
Conclusion
No evidence of an association between diabetes and AD neuropathology was found in a large sample of Brazilians; however, certain subgroups, such as APOE allele ε4 carriers, had higher odds of accumulation of neurofibrillary tangles.